HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Neutropenic enterocolitis in adults with acute leukemia].

Abstract
Neutropenic enterocolitis, also known as typhlitis or ileocecal syndrome, in leukemic patients undergoing chemotherapy has a high reported mortality. A recent increase in the incidence of neutropenic enterocolitis is associated with aggressive chemotherapy for acute leukemia. In this report, we report the incidence, diagnosis, and treatment of neutropenic enterocolitis during low-dose DCMP and high-dose DCMP regimen for 95 adults with acute nonlymphocytic leukemia, and review the literature pertaining appropriate medical and surgical management, and method of prevention. Finally we propose the favorable results of gut sterilization for the treatment and prevention of the disease.
AuthorsY Uzuka, Y Saito, H Takahashi, M Komatu, T Ito
Journal[Rinshò„ ketsueki] The Japanese journal of clinical hematology (Rinsho Ketsueki) Vol. 30 Issue 7 Pg. 980-7 (Jul 1989) ISSN: 0485-1439 [Print] JAPAN
PMID2810800 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Cytarabine
  • Prednisolone
  • 6-Mercaptopurine
  • Daunorubicin
Topics
  • 6-Mercaptopurine (administration & dosage)
  • Adult
  • Agranulocytosis (etiology)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Cohort Studies
  • Cytarabine (administration & dosage)
  • Daunorubicin (administration & dosage)
  • Enterocolitis, Pseudomembranous (epidemiology, etiology)
  • Female
  • Humans
  • Leukemia, Myeloid, Acute (complications, drug therapy)
  • Male
  • Middle Aged
  • Neutropenia (epidemiology, etiology)
  • Prednisolone (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: